Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 121,621 shares at $149.03 ($18.2M) on 2023-03-15, disclosed to the SEC on 2023-03-17.
Seasonal sale ($18.2M) by Chief Executive Officer — this insider has traded MRNA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.33 | 15,472 | $2.3M | 12.6% |
| 2 | $148.33 | 15,472 | $2.3M | 12.6% |
| 3 | $149.03 | 22,481 | $3.4M | 18.4% |
| 4 | $149.03 | 22,481 | $3.4M | 18.4% |
| 5 | $150.00 | 1,847 | $277K | 1.5% |
| 6 | $150.72 | 200 |
| $30K |
| 0.2% |
| 7 | $148.63 | 4,200 | $624K | 3.4% |
| 8 | $149.81 | 7,500 | $1.1M | 6.2% |
| 9 | $150.39 | 7,600 | $1.1M | 6.3% |
| 10 | $151.75 | 17,032 | $2.6M | 14.2% |
| 11 | $152.49 | 3,668 | $559K | 3.1% |
| 12 | $152.49 | 3,668 | $559K | 3.1% |
| Total | $149.58 avg | 121,621 | $18.2M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |